Harel Insurance Investments & Financial Services’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-29,410
Closed -$74K 815
2023
Q1
$74K Hold
29,410
﹤0.01% 443
2022
Q4
$54K Hold
29,410
﹤0.01% 466
2022
Q3
$200K Hold
29,410
﹤0.01% 295
2022
Q2
$318K Hold
29,410
0.01% 291
2022
Q1
$659K Hold
29,410
0.01% 230
2021
Q4
$831K Buy
+29,410
New +$1.28M 0.02% 187

Other funds holding ELOX

Harel Insurance Investments & Financial Services's ELOX Position: Q2 2023 in Review

Harel Insurance Investments & Financial Services sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q2 2023, closing a stake of 29,410 shares — an estimated $74K sold.

Harel Insurance Investments & Financial Services first reported a position in ELOX in Q4 2021 and held it in 6 quarters. The position peaked at $831K in Q4 2021. 16 funds tracked by Wall St. Rank hold ELOX as of Q2 2023.

  • Harel Insurance Investments & Financial Services reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 29,410 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q2 2023, an estimated $74K.
  • Harel Insurance Investments & Financial Services first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q4 2021 and held it in 6 quarters.
  • Harel Insurance Investments & Financial Services's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $831K in Q4 2021.
  • 16 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q2 2023.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q2 2023, filed 17 Jul 2023.